News & Media

As a recognized industry leader, AlloSource serves as a subject matter expert for everything from tissue processing to innovation. We invite you to learn more about how we Do More With Life.

AlloSource Announces First Implant Of AceConnex™ Pre-Sutured Fascia Device In Hip Labral Reconstruction Procedure

AlloSource Announces First Patient Implantation in United Kingdom Clinical Evaluation of ProChondrix CR Cryopreserved Osteochondral Allograft

AlloSource Announces Poster Featuring Prochondrix CR Osteochondral Allograft Clinical Outcomes at the 17th International Cartilage Regeneration & Joint Preservation Society (ICRS) World Congress

AlloSource Receives FDA 510(k) Clearance for AceConnex™ Pre-Sutured Fascia for Hip Labral Reconstruction and Augmentation

Study on ProChondrix Osteochondral Allograft Published in the Journal of Orthopaedic Surgery Demonstrates Encouraging Outcomes When Used on Isolated Articular Cartilage Defects

AlloSource Launches AlloMend Duo Acellular Dermal Matrix, A Natural Solution For Non-Directional Implantation in Soft Tissue Reconstruction

ProChondrix CR, AlloSource’s Novel Laser Etched Cryopreserved Osteochondral Allograft, Shows Positive Patient-Reported Outcomes in Prospective Clinical Study on Focal Articular Cartilage Defects in the Knee

AlloSource Recognized with Cigna Healthy Workforce Designation

View All Press Releases
AlloSource

For More Information

Please contact Colleen Kilkenny at ckilkenny@allosource.org or
720. 382. 2756 if you are interested in information on our company, our experts and our mission-driven work.